aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.8990
+0.0883 (10.89%)
At close: Feb 6, 2026, 4:00 PM EST
0.8800
-0.0190 (-2.11%)
After-hours: Feb 6, 2026, 7:58 PM EST

aTyr Pharma Revenue

aTyr Pharma had revenue of $190.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $190.00K, down -19.15% year-over-year. In the year 2024, aTyr Pharma had annual revenue of $235.00K, down -33.43%.

Revenue (ttm)
$190.00K
Revenue Growth
-19.15%
P/S Ratio
463.63
Revenue / Employee
$2,923
Employees
65
Market Cap
88.09M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024235.00K-118.00K-33.43%
Dec 31, 2023353.00K-10.03M-96.60%
Dec 31, 202210.39M--
Dec 31, 2021---
Dec 31, 202010.46M10.03M2,377.49%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Pelthos Therapeutics7.41M
ImageneBio800.00K
Precision BioSciences698.00K
Spruce Biosciences697.00K
MediciNova257.92K
Revenue Rankings